Dr. Straube is currently a Director at the Marwood Group, a healthcare advisory and financial services firm headquartered in New York City with offices in Washington, DC, London and Kuwait. The Marwood Group provides services to institutional investors, corporations and trade associations. Prior to joining the Marwood Group in 2011, he was Chief Medical Officer for the Centers for Medicare and Medicaid Services (CMS), as well as the Director of the CMS Office of Clinical Standards and Quality (OCSQ). Serving in those roles from 2005 to 2011, Dr. Straube was the most senior clinical advisor to the CMS Administrator and CMS leadership.
Mr. Ferrara was appointed to the Board of Holdco by Ontario Teachers’ Pension Plan (OTPP), Holdco’s majority stockholder, in November 2014 and also serves as Vice President of Holdco and PhyMed. Mr. Ferrara joined TPC in 2006 after spending more than a decade in banking and M&A/corporate development at a private equity backed global enterprise. He has participated in investments in PhyMed, Heartland Dental, CTVglobemedia, Grupo Corporativo Ono, Avaya Inc., GNC, PhyMed Healthcare Group and Flexera Software. He currently sits on the boards of Heartland and PhyMed Healthcare Group. Mr. Ferrara holds a B.Sc. (Honours) and an MBA from the University of Toronto (Rotman). He is a Chartered Accountant and a Chartered Business Valuator.
Dr. Ferrell has been a physician with Anesthesia Medical Group (AMG) since 1993, serving on the AMG Board of Directors from 2000 to 2007. He has played a key role in partnering with hospital leaders, establishing the Perioperative Transesophageal Echocardiography Program at Centennial Medical Center and chairing the leadership group in opening the Centennial Heart Center in Nashville in 2001. Dr. Ferrell is Board Certified in Anesthesiology and Perioperative Transesophageal Echocardiography.
Mr. Breckon was appointed to the Board of Holdco by Ontario Teachers’ Pension Plan (OTPP), Holdco’s majority stockholder, in November 2014. Mr. Breckon has over 20 years of operating and M&A experience in the global health and life sciences sector, including diagnostics, drug development services, instrumentation, nuclear medicine and sterilization, having served in a number of senior executive roles at Nordion Inc. (formerly known as MDS Inc.). He was most recently Senior Vice President, Strategy & Corporate Development at MDS prior to joining TPC in 2010 as a Senior Advisor. He was also previously a Partner at Ernst & Young. Mr. Breckon has been a director of more than a dozen public and privately held companies and investment funds in Canada and the United States and is currently a director of INC Research and PhyMed Healthcare Group. Mr. Breckon holds a joint B.Sc. in Commerce/Computer Science from the University of Toronto and is a graduate of Harvard’s Advanced Management Program.
Dr. Forrest is the Chief Medical Officer and PhyMed Board member. He has been a physician partner with Anesthesia Medical Group (AMG) since 1995. He is responsible for the clinical oversight of the organization to include clinical operations and quality programs. Dr. Forrest has held multiple administrative roles within the practice to include Chief of Anesthesia and President of the AMG Board of Directors for six years. Dr. Forrest completed his medical degree from the University of Alabama as well as his fellowship and residency at Emory University in Cardiothoracic Anesthesiology.
Dr. Forrest is board certified by the American Board of Anesthesiology and national Board of Echocardiography in Perioperative Transesophageal Echocardiography.
Mr. Abbasi has significant experience in leading hospital-based services organizations, most recently as President and CEO of American Pathology Partners, Inc., a leading laboratory services and cancer diagnostics company located in Brentwood, TN with operations in 11 states. Prior to this, Mr. Abbasi was the Chairman and CEO of National Surgical Care, Inc. based in Dallas, TX, owning and operating 22 surgery centers in 11 states until the company’s sale to AMSURG in 2011. Mr. Abbasi also served as President and CEO of Radiologix, a publicly traded national provider of diagnostic imaging services and one of Forbes magazine’s top 200 companies in 2002.
Mr. Abbasi has also held senior leadership positions at AdminiQuest, Robertson, Stephens & Company and Citicorp. He received his BA in Economics from the University of Pennsylvania and MBA from the University of Rochester.
Terry Woodward has served as a member of our Board since November 2014. Dr. Woodward currently serves as a Director of Teachers’ Private Capital, which he joined in 2001. Prior to joining Teacher’s, Dr. Woodward held senior positions in corporate development and clinical research and development at privately-held biopharmaceutical and medical diagnostic companies in the United States. Dr. Woodward manages the funds private equity transactions in the healthcare sector and oversees growth equity and venture capital sectors.
Dr. Woodward currently serves as a director of PhyMed Healthcare Group, INC Research, PetVet Care Centers and the Healthcare Private Equity Association. He received his Bachelor of Science and Master of Science from Virginia Polytechnic Institute and State University, his Ph.D. from McGill University and his M.B.A. from Michigan State University.
From 2000 to 2016, Dr. Nussbaum served as Executive Vice President, Clinical Health Policy, and Chief Medical Officer for Anthem, where he was the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy.
Among his other positions, he served as Executive Vice President, Medical Affairs and System Integration of BJC Health Care, where he led integrated clinical services and served as President of its medical group and Chairman of its commercial and Medicaid health plans.
Dr. Nussbaum served as a professor and clinical leader at Harvard Medical School and Massachusetts General Hospital, where he led basic science research, drug discovery, clinical studies, teaching and patient care. He has been recognized by Modern Healthcare as one of the “50 Most Influential Physician Executives in Healthcare.”
Dr. Nussbaum currently serves as Chair of a public-private work group established by the Department of Health and Human Services to develop the framework for alternate payment models to enhance patient-centered care and reduce waste in healthcare. He is also a Professor of Clinical Medicine at Washington University School of Medicine and serves as adjunct professor at the Olin School of Business, Washington University.
Lopes is currently Chairman of the board at Surgical Solutions, LLC, which provides support services that include technicians, disposables, instrumentation and repairs for minimally invasive procedures. He is also currently Vice Chair of Ameritox, which offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients.
Among his previous positions, Lopes served as CEO of Ameritox. He also held the role of Sr. Vice President and Division President of Coventry Health Care, which offers a variety of health care plans, and CEO of St. Louis Connect Care, which provided outpatient specialty medical services.